Clinical Trial Update: Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder. [Phase 3]

View source ↗

Summary

Pfizer's long-term Phase 3 trial assessing the safety, tolerability, and efficacy of fesoterodine for overactive bladder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2010-08-11